Contrast Injector Market

Global Contrast Injector Market Size (2022 to 2027)

As per our report, the size of the global contrast injector market was worth USD 566.55 million in 2022 and is projected to be growing at a CAGR of 8.1% and will reach USD 836.31 million by 2027.

The contrast injector is used to inject contrast media or contrast agents into the blood to increase the contrast of the structure of fluids within the body in medical imaging. The contrast media absorb or alter the external electromagnetism or the ultrasound and give an accurate image in medical imaging. Contrast media are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. There are different contrasts media used in medical imaging, depending on the type of medical imaging. An automation injection system helps to deliver a precise amount of contrast.

The injection of contrast media enables visualization of various ailments through X-ray, computed tomography, magnetic resonance, or other different medical-imaging modalities into the bloodstream. The delivery of contrast media is considered most effective by implementing a medical device for this purpose, known as a contrast injector or power injector.

Plungers, in contrast, injectors, push the contrast media into the tubing connected to a patient’s vascular system. Contrast injectors are controlled by a computer-controlled unit in the room, where volumes and flow rates of the media are programs and the start & stop mechanisms are controlled. The device can be programmed to deliver specific amounts of contrast agents at accurate flow rates.

MARKET DRIVERS:

The growing number of contrast agent approvals and developments in the technology increasing funding by the governments primarily propel the global contrast injector market.

The use of medical imaging in the healthcare sector is increasing the demand for more accurate imaging, which is estimated to support the growth of the global contrast injector market. Growing awareness of the benefits of the utilization of these injectors is enhancing the demand of the market. Increasing investments in innovative products in healthcare is likely to bolster the market's growth rate.  The key players in the market are using different software and I.T. to improve the technological solutions, which is offering growth scope to the market.

MARKET RESTRAINTS:

The shortage of trained and skilled professionals to operate also impedes the demand of the contrast injector market. Some people experience rash, skin redness, vomiting, or dizziness which could last for one hour or longer with the regular use of a contrast injector, which is projected to hamper the growth rate of the contrast injector market to some extent.

Impact of Covid-19 on the global contrast injector market:

The pandemic has had a serious impact on hospitals and the economy around the world. Several medical facilities were told to stop performing elective surgical procedures and medical tests to prevent the spread of the disease and save healthcare services for COVID-19 patients. Contrast media injector devices are known for injecting contrast media or agents into the body to increase tissue exposure during medical imaging procedures. During the treatment, these media injectors provide a continuous and controlled flow of contrast media into the patient's body. Many imaging techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography, are used to diagnose. The need for contrast injectors would be largely determined by the amount of diagnostic imaging and the number of CT and MRI machines installed. During this pandemic, diagnostic imaging demand increased due to increased demand for the contrast injector market. As a result, Covid-19 will have a positive effect on the growth of the contrast injector market.

REPORT COVERAGE:

This research report on the global contrast injector market has been segmented and sub-segmented based on the product, application, and region.

Contrast Injector Market - By Product:

• Injector Systems    
• Consumables          
• Accessories      

The consumables segment is expected to have the highest growth during the forecast period based on the product. Growing necessities of consumables to conserve welfare and sterilized conditions during the diagnostic processes are majorly attributing to the market growth.

The injector systems are followed after the consumable segment in showcasing the quickest growth. The injectors system is further sub-segmented into CT injectors, MRI injectors, and Angiography injectors. The CT injectors segment is estimated to display a lucrative growth rate during the forecast period.

Contrast Injector Market - By Application:

• Radiology 
• Interventional Cardiology  
• Interventional Radiology 

Based on the application, the radiology segment is anticipated to hold the largest share of the global contrast injector market during the forecast period. The growth is accredited due to the increasing number of radiology procedures that use contrast media. This segment is estimated to produce profitable growth due to the demand for non-invasive medical imaging techniques.

The interventional cardiology segment is projected to have the quickest growth rate during the period. The growth is due to an average increase in cardiac diseases such as stroke, heart attack, and heart valve problems.   

Contrast Injector Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

As of 2019, North America leads the market, accounting for the significant global market share, with the U.S. accounting for the considerable share. Europe comes in second in terms of market share. However, Asia-Pacific is expected to expand at the highest CAGR during the forecast period, majorly because of the increasing feasibility of approvals for the use of contrast media and the market potential offered by the region to companies producing contrast injectors.

KEY MARKET PARTICIPANTS:

Some of the noteworthy companies operating in the global contrast injector market profiled in the report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtronic AG (Germany), Ulrich GmbH & Co. K.G. (Germany), G.E. Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo R.T. Co., Ltd. (China).

RECENT MARKET DEVELOPMENTS:

• On April 21, 2020, Guerbet announced that it received US FDA approval to manufacture Dotarem injection.
• On December 24, 2019, the Bayer AG Leverkusen Germany launched its new MEDRAD Stellent FLEX CT injection system. It helps to control the administration of intravenous C.T. contrast media. 
• On November 4, 2019, G.H. Healthcare announced US FDA approval for macrocyclic MRI contrast agent clariscan. It is a gadolinium-based contrast agent.